Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 19 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 29, 2026 –…
Natco Pharma's Q4 net down 34% at ₹269 cr
Natco Pharma's consolidated net profit declined 34 percent at ₹269 crore in the fourth quarter of last financial year ended March 31, 2026 compared to ₹406 crore in the corresponding quarter previous year. The total revenue of the…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0815 GMT – Bayer's pharmaceutical business has good momentum but faces risks over the medium term from…
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most…
Stock Split Watch: Is Eli Lilly Next?
Eli Lilly (LLY 1.93%) may not immediately come to mind when you think of growth stocks. Instead, you might think of technology or even consumer-oriented players. But Lilly actually has shown itself to be a top growth player in recent quarters, and…
Three companies receive SEBI'S nod to float IPOs
Rodec Pharma, Renny Strips, and Krishna Buildspace have secured SEBI's approval to raise funds t hrough initial public offerings (IPOs), an update with the markets regulator showed on Friday. Renny Strips Ltd, a steel structural products…
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
The study enrolled 71 patients who had previously received platinum-based chemotherapy and immunotherapy (pre-treated patients) and 92 patients who had not received prior systemic therapy (treatment-naïve patients). As of the data cutoff date…
Intech Investment Management LLC Has $12.49 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
Intech Investment Management LLC lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange…
She criticizes capitalism - and also gives investing advice: 'It's better to participate than working until we die'
Amanda Holden is, in her words, an “ex-finance bro”. She landed a job in investment management right out of college and was earning a six-figure income by her early 20s. But after five years of “letting grown men scream at me…
Icon Public (ICLR) Q4 2025 Earnings Transcript
Thursday, May 28, 2026, at 8 a.m. ET Chief Executive Officer — Barry Balfe Chief Financial Officer — Nigel Clerkin Head of Investor Relations — Kate Haven Accounting investigation and restatements -- Revenue restatements…
AdvisorShares Investments LLC Purchases New Stake in Teva Pharmaceutical Industries Ltd. $TEVA
AdvisorShares Investments LLC purchased a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The…
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Moderna, Inc. (MRNA) Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 10:00 AM EDT Stéphane Bancel – CEO & Director Courtney Breen – Bernstein Institutional Services LLC, Research Division Bernstein…
This Global ETF Beat the Nasdaq-100 for Most of the Past Year. Should You Buy It?
Usually, tech stocks are the best place to put your money, right? Not always. International dividend stocks have been strong lately. Until mid-April, the Vanguard International High Dividend Yield ETF (VYMI +0.40%) had outperformed the Invesco QQQ…
Quebec lawyers finding creative ways to reach potential opioid class-action members - Montreal
When Caroline Rivest broke her ankle a few years ago, a doctor prescribed her a powerful opioid for three months to help with the pain. She was hooked in no time. After her prescription ran out, she turned to the black market to keep the withdrawal…
Investigating how hormones affect brain health
UL's Prof George Barreto discusses his research and how it could help form new treatments for treating and protecting the brain. Prof George Barreto is a professor in cell biology/immunology at the University of Limerick (UL) and a neuroscientist.
Receive a Daily briefing on Pharma Industry News
Get Started